279 related articles for article (PubMed ID: 2982003)
1. TDI-induced oculorhinitis and bronchial asthma.
Paggiaro PL; Rossi O; Lastrucci L; Pardi F; Pezzini A; Baschieri L
J Occup Med; 1985 Jan; 27(1):51-2. PubMed ID: 2982003
[TBL] [Abstract][Full Text] [Related]
2. Specific bronchial provocation tests in occupational asthma and methods of stimulation: case report.
Moscato G; Biscaldi G; Cottica D; Candura F
G Ital Med Lav; 1983 Nov; 5(6):259-61. PubMed ID: 6100489
[TBL] [Abstract][Full Text] [Related]
3. [Occupational toluene diisocyanate (TDI) asthma--inhalation challenge test and TDI-HSA (human serum albumin) skin test and detection of specific IgE].
Duan YY
Zhonghua Jie He He Hu Xi Za Zhi; 1989 Jun; 12(3):149-52, 191. PubMed ID: 2553281
[TBL] [Abstract][Full Text] [Related]
4. Toluene diisocyanate-induced asthma without airway hyperresponsiveness.
Mapp CE; Dal Vecchio L; Boschetto P; De Marzo N; Fabbri LM
Eur J Respir Dis; 1986 Feb; 68(2):89-95. PubMed ID: 3009212
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
Park HS; Nahm DH
Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254
[TBL] [Abstract][Full Text] [Related]
6. Late, but not early, asthmatic reactions induced by toluene-diisocyanate are associated with increased airway responsiveness to methacholine.
Mapp CE; Di Giacomo GR; Omini C; Broseghini C; Fabbri LM
Eur J Respir Dis; 1986 Oct; 69(4):276-84. PubMed ID: 3028853
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma.
Choi JH; Nahm DH; Kim SH; Kim YS; Suh CH; Park HS; Ahn SW
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):293-8. PubMed ID: 15478392
[TBL] [Abstract][Full Text] [Related]
8. Persistent airways disease caused by toluene diisocyanate.
Moller DR; McKay RT; Bernstein IL; Brooks SM
Am Rev Respir Dis; 1986 Jul; 134(1):175-6. PubMed ID: 3014935
[TBL] [Abstract][Full Text] [Related]
9. [The response to a specific bronchial provocation test and the evolution of occupational asthma. A longitudinal study in subjects with toluene diisocyanate-induced asthma].
Marabini A; Brugnami G; Curradi F; Severini C; Siracusa A
Med Lav; 1994; 85(2):134-41. PubMed ID: 8072441
[TBL] [Abstract][Full Text] [Related]
10. Seroimmunological characteristics of Korean workers exposed to toluene diisocyanate.
Kim H; Kim YD; Choi J
Environ Res; 1997 Oct; 75(1):1-6. PubMed ID: 9356188
[TBL] [Abstract][Full Text] [Related]
11. [Changes in blood eosinophils and nonspecific bronchial reactivity after exposure tests to wheat flour and TDI].
De Zotti R; Gubian F; Negro C
Med Lav; 1996; 87(2):152-61. PubMed ID: 8926918
[TBL] [Abstract][Full Text] [Related]
12. A prospective and immunologic study of factory workers exposed to TDI (toluene diisocyanate).
Duce F; de Gregorio MA; Pérez J; Portillo JR; Pascual G; Alfonso ER
Allergol Immunopathol (Madr); 1988; 16(3):139-44. PubMed ID: 2845764
[TBL] [Abstract][Full Text] [Related]
13. [Diseases caused by diisocyanates. 2. Diisocyanate asthma].
Lubach D
Derm Beruf Umwelt; 1979; 27(1):5-10. PubMed ID: 226341
[TBL] [Abstract][Full Text] [Related]
14. [Toluene diisocyanate asthma. 1. Clinico-immunological evaluation].
Kido T; Yamada Y; Teranishi H; Daimon N; Shimizu T
Arerugi; 1983 Feb; 32(2):111-20. PubMed ID: 6311143
[No Abstract] [Full Text] [Related]
15. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma.
Choi JH; Lee KW; Kim CW; Park CS; Lee HY; Hur GY; Kim SH; Hong CS; Jang AS; Park HS
Int Arch Allergy Immunol; 2009; 150(2):156-63. PubMed ID: 19439981
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of late asthmatic reactions induced by exposure to isocyanates.
Mapp CE; Boschetto P; Zocca E; Milani GF; Pivirotto F; Tegazzin V; Fabbri LM
Bull Eur Physiopathol Respir; 1987; 23(6):583-6. PubMed ID: 2840139
[TBL] [Abstract][Full Text] [Related]
17. The case of TDI-induced reactive airway dysfunction syndrome with the presence of specific IgE antibodies.
Palczyński C; Górski P; Jakubowski J
Allergol Immunopathol (Madr); 1994; 22(2):80-2. PubMed ID: 8059679
[TBL] [Abstract][Full Text] [Related]
18. The development of an animal model for TDI asthma.
Karol MH
Bull Eur Physiopathol Respir; 1987; 23(6):571-6. PubMed ID: 2456109
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological evaluation of isocyanate-exposed workers.
Park HS; Park JN; Kim JW; Kim SK
J Korean Med Sci; 1992 Jun; 7(2):122-7. PubMed ID: 1326284
[TBL] [Abstract][Full Text] [Related]
20. Isophorone diisocyanate induced respiratory disease (IPDI).
Clarke CW; Aldons PM
Aust N Z J Med; 1981 Jun; 11(3):290-2. PubMed ID: 6945844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]